Tristel plc
("Tristel" or "the Company")
Director Dealing/Issue of Equity
Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, today announces that 87,500 ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") have been issued and allotted pursuant to the exercise of share options under the Senior Management Share Option Scheme.
The above ordinary shares have been allotted to Paul Barnes a Non-executive Director of the Company. Following the exercise of options, Mr Barnes holds 700,180 ordinary shares, representing 1.7% of the issued share capital, and 87,500 options under the Senior Management Share Option Scheme.
Application has been made for the 87,500 new Ordinary Shares to be admitted to trading on AIM ("Admission") and dealings are expected to commence on 24 June 2015. The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares.
The total number of Ordinary Shares in issue following Admission will be 41,242,201. Accordingly, the figure of 41,242,201 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.
For further information please contact:
Tristel plc |
www.tristel.com |
Paul Swinney, Chief Executive Officer |
Tel: 01638 721 500 |
Liz Dixon, Finance Director |
|
|
|
Walbrook PR Ltd |
Tel: 020 7933 8780 or [email protected] |
Paul McManus |
Mob: 07980 541 893 |
Lianne Cawthorne |
Mob: 07854 391 303 |
|
|
finnCap |
Tel: 020 7220 0500 |
Geoff Nash (Corporate Finance) |
|
Giles Rolls (Corporate Finance) |
|
Stephen Norcross (Corporate Broking) |
|
